Translating tolerogenic therapies to the clinic - where do we stand?
Manipulation of the immune system to prevent the development of a specific immune response is an ideal strategy to improve outcomes after transplantation. A number of experimental techniques exploiting central and peripheral tolerance mechanisms have demonstrated success, leading to the first early...
主要な著者: | Issa, F, Wood, K |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2012
|
類似資料
-
Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers?
著者:: Cobbold, S, 等
出版事項: (2012) -
Translating tolerogenic therapies to the clinic – where do we stand and what are the barriers?
著者:: Stephen Paul Cobbold, 等
出版事項: (2012-10-01) -
Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
著者:: Eros Marín, 等
出版事項: (2018-02-01) -
Clinical Microbiology: where do we stand?
著者:: Alkiviadis Vatopoulos
出版事項: (2024-06-01) -
Gene therapy for clinical transplantation: where do we stand in 2006?
著者:: Tan, P, 等
出版事項: (2006)